CIRM Directors Tackle Grant Appeal Problems
The longstanding issues involving appeals of grant reviewer decisions at the $3 billion California stem cell agency will be taken up once again April 26 by the directors' Science Subcommittee.
The agenda also includes possible action on a bank for reprogrammed stem cells.
No details are yet available on any of the proposals to be considered, but potenti…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.